GiaprosVITsatsoulisAADrougiaEA, et al.Rare causes of acute hyperkalemia in the 1st week of life. Three case reports. Pediatr Nephrol2004; 19: 1046–1049.
2.
FinkelsteinMSchaeferJM. Inborn errors of steroid biosynthesis. Physiol Rev1979; 59: 353–406.
3.
DupontBOberfieldSESmithwickEM, et al.Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet1977; 2: 1309–1312.
4.
NimkarnS. Disorders of the Adrenal Gland, 9th edn. Philadelphia, PA: Elsevier Science, 2012.
5.
KohnBLevineLSPollackMS, et al.Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab1982; 55: 817–827.
SpeiserPWAzzizRBaskinLS, et al.Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2010; 95: 4133–4160.
8.
BonfigWBechtoldSSchmidtH, et al.Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. J Clin Endocrinol Metab2007; 92: 1635–1639.
9.
GomesLGMadureiraGMendoncaBB, et al.Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clinics2013; 68: 147–151.
10.
MullisPEHindmarshPCBrookCG. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. Eur J Pediatr1990; 150: 22–25.
11.
MartinerieLPussardEFoix-L’HeliasL, et al.Physiological partial aldosterone resistance in human newborns. Pediatr Res2009; 66: 323–328.
12.
HoltbackUAperiaAC. Molecular determinants of sodium and water balance during early human development. Semin Neonatol2003; 8: 291–299.
13.
Al-DahhanJHaycockGBChantlerC, et al.Sodium homeostasis in term and preterm neonates. I. Renal aspects. Arch Dis Child1983; 58: 335–342.
14.
WhitePC. Congenital Adrenal Hyperplasia and Related Disorders, 20th edn. Philadelphia, PA: Elsevier Science, 2015.
15.
AycanZOcalGBerberogluM, et al.Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential. J Pediatr Endocrinol Metab2006; 19: 245–251.
16.
Mendes-Dos-SantosCTLemos-MariniSHBaptistaMT, et al.Normalization of height and excess body fat in children with salt-wasting 21-hydroxylase deficiency. J Pediatr (Rio J)2011; 87: 263–268.
17.
HindmarshPC. Management of the child with congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab2009; 23: 193–208.
18.
LevinTLAbramsonSJBurbigeKA, et al.Salt losing nephropathy simulating congenital adrenal hyperplasia in infants with obstructive uropathy and/or vesicoureteral reflux—value of ultrasonography in diagnosis. Pediatr Radiol1991; 21: 413–415.
19.
MastrandreaLDMartinDJSpringateJE. Clinical and biochemical similarities between reflux/obstructive uropathy and salt-wasting congenital adrenal hyperplasia. Clin Pediatr (Phila)2005; 44: 809–812.
20.
ClohertyJP. Manual of Neonatal Care, 7th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2012.
21.
WhitePCCongenital adrenal hyperplasia and related disorders. In: KliegmanRM (ed). Nelson Textbook of Pediatrics, 1st South Asia edn. New Delhi: Elsevier, 2016, pp. 2714–2720.
